Guide
June 10, 2026
Don't buy peptides without checking the COA. Learn how to read HPLC purity, mass spectrometry verification, endotoxin testing, and sterility — so you know exactly what you're put
Review
June 10, 2026
The FDA's Pharmacy Compounding Advisory Committee meets July 23-24, 2026 to review BPC-157, TB-500, KPV, MOTS-C, DSIP, Semax, and Epitalon for 503A compounding. Here's what women n
Guide
June 09, 2026
Step-by-step guide to peptide reconstitution and subcutaneous injection, written for women. Covers supplies, dosing math, injection sites, storage, and common mistakes.
GLP-1 & Weight Loss
June 09, 2026
TRIUMPH-1 Phase 3 data shows retatrutide achieved up to 30.3% average weight loss. Analysis of what the triple agonist means for women — menopause, HRT synergy, and the GLP-1 lan
Article
June 08, 2026
Evidence-based overview of peptides relevant to postpartum recovery. Covers tissue repair (BPC-157, TB-500), collagen restoration (GHK-Cu), energy (NAD+), and safety considerations
Article
June 08, 2026
An evidence-based guide to peptides for perimenopause. Covers hot flashes, brain fog, weight gain, sleep, and mood — mapped to specific peptides with PubMed citations. Written fo
GLP-1 & Weight Loss
June 07, 2026
ENDO-205, the first targeted peptide therapeutic for endometriosis, received FDA IND clearance in March 2026. What this means for the 190 million women affected worldwide.
Article
June 07, 2026
Evidence-based guide to peptides for anxiety and sleep in women. Selank showed anxiolytic effects comparable to benzodiazepines. DSIP enhances delta-wave deep sleep. PubMed-cited.
GLP-1 & Weight Loss
June 06, 2026
How to build a comprehensive menopause peptide protocol. Covers GH axis, metabolic support, skin/collagen, mood/sleep, and libido — with specific peptide recommendations for each
GLP-1 & Weight Loss
June 06, 2026
Practical guide to finding a qualified peptide therapy provider. Covers credentials, red flags, telehealth vs in-person, what to expect from your first visit, and questions to ask.
Review
June 05, 2026
A 2024 pilot study showed BPC-157 bladder injections resolved symptoms in 10 of 12 women with severe interstitial cystitis. What this means, what the limitations are, and what's ne
Comparison
June 05, 2026
Both target fat metabolism. One has FDA approval. The other avoids full GH effects. Here's the head-to-head comparison for menopausal belly fat.
GLP-1 & Weight Loss
June 04, 2026
Semaglutide targets GLP-1 alone. Retatrutide adds GIP and glucagon receptors for triple-agonist action. Here's how they compare for women's weight management and PCOS.
Article
June 04, 2026
Selank targets anxiety through GABA/serotonin modulation. DSIP targets sleep through delta-wave promotion. Here's when to use each — and when to stack them together.
Article
June 03, 2026
NAD+ fuels mitochondrial energy. Epitalon maintains telomere length. Both target cellular aging — through different mechanisms. Here's how they compare and why many women use bot
GLP-1 & Weight Loss
June 03, 2026
The right peptides change as your body changes. Here's a decade-by-decade guide — 40s (perimenopause), 50s (menopause), 60s+ (longevity) — with specific peptide recommendations
Hair Loss
June 02, 2026
Women lose up to 50% of hair density by age 50. GHK-Cu reduces DHT conversion, boosts collagen in follicles, and influences 4,000+ genes. A 2026 review calls it the top peptide for
Article
June 02, 2026
80% of autoimmune patients are female. KPV — a potent anti-inflammatory tripeptide — inhibits NF-κB signaling and modulates gut-immune axis dysfunction. Here's the evidence fo
Article
June 01, 2026
A landmark study used kisspeptin-54 as an IVF trigger and produced 73 healthy babies with zero cases of ovarian hyperstimulation syndrome. Here's what every woman considering ferti
Article
June 01, 2026
Epitalon reactivates telomerase, extends telomere length, and restores melatonin production from the pineal gland. It targets 5 hallmarks of aging simultaneously. Here's the eviden
Article
May 31, 2026
The most prescribed peptide combination in functional medicine. CJC-1295/Ipamorelin restores growth hormone pulsing for sleep, body composition, skin, and the brain fog of perimeno
Article
May 31, 2026
Anxiety disorders are 2x more prevalent in women. Selank modulates GABA and serotonin without sedation, dependence, or cognitive impairment. Here's the evidence for the anxiolytic
GLP-1 & Weight Loss
May 30, 2026
Menopause affects multiple systems simultaneously — so effective peptide protocols often combine multiple compounds. Here are 5 evidence-informed stacking frameworks organized by
GLP-1 & Weight Loss
May 30, 2026
Not all peptide suppliers are created equal. Here's how to read a COA, what to look for in a vendor, which side effects are normal vs concerning, and what bloodwork to monitor.
GLP-1 & Weight Loss
May 29, 2026
Menopause belly fat isn't a willpower issue — it's hormonal biology. Tesamorelin (FDA-approved), AOD-9604, and MOTS-C target visceral fat through mechanisms diet alone can't reac
Article
May 29, 2026
Perimenopause insomnia is brutal — and melatonin often isn't enough. DSIP (Delta Sleep-Inducing Peptide) promotes the slow-wave deep sleep that hormonal changes disrupt.
Men's Health
May 28, 2026
PT-141 (Vyleesi) is the only FDA-approved on-demand treatment for low sexual desire in women. It works on the brain, not blood flow. Phase 3 trials with 1,200+ women. Here's everyt
Article
May 28, 2026
NAD+ decline accelerates at 45 — right when perimenopause hits. The result is a double energy crisis: estrogen drops AND cellular energy drops. Here's how NAD+ addresses the fati
Article
May 27, 2026
Glutathione depletion accelerates during menopause — driving visible aging, hyperpigmentation, and oxidative damage. Here's how the body's master antioxidant supports skin bright
Article
May 27, 2026
Women lose 30% of their collagen in the first 5 years after menopause. GHK-Cu — a naturally occurring copper peptide — stimulates collagen production, supports hair growth, and
Review
May 26, 2026
IBS is 2x more common in women. A pilot study showed 10 of 12 women with interstitial cystitis achieved 80-100% symptom resolution with BPC-157. Here's the complete evidence review
GLP-1 & Weight Loss
May 26, 2026
An evidence-based review of peptides for polycystic ovary syndrome — Kisspeptin-10, MOTS-C, Semaglutide, BPC-157, and NAD+. PubMed-cited. Written for women.
Article
May 25, 2026
HRT addresses sex hormone deficiency. Peptides target the parallel axes — growth hormone, tissue repair, immune signaling — that estrogen replacement alone doesn't cover.
Telehealth
May 25, 2026
A complete timeline of the FDA's peptide reclassification — from the 2023 Category 2 restrictions to the April 2026 removal of 12 peptides and the upcoming July PCAC review.
GLP-1 & Weight Loss
May 25, 2026
Not all peptides require needles. A guide to oral BPC-157, collagen peptides, sublingual options, and how bioavailability affects your results.
No articles found matching your search.